Corporate News     08-Aug-22
Alembic Pharmaceuticals receives USFDA approval for Adapalene and Benzoyl Peroxide Topical Gel
Alembic Pharmaceuticals (Alembic) today announced that its wholly owned subsidiary, Aleor Dermaceuticals (Aleor) has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5%. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Epiduo Forte Topical Gel, 0.3%/2.5%, of Galderma Laboratories, L.P; (Galderma). Adapalene and Benzoy Peroxide Topical Gel, 0.3%/2.5% is indicated for the topical treatment of acne vulgaris in adults and pediatric patients 12 years of age and older.

Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5% has an estimated market size of US$211 million for twelve months ending Mar 2022 according to IQVIA.

Alembic has received a cumulative total of 170 ANDA approvals (146 final approvals and 24 tentative approvals) from USFDA.

Previous News
  Alembic Pharmaceuticals receives USFDA approval for Sacubitril and Valsartan Tablets
 ( Corporate News - 30-May-24   14:49 )
  Alembic Pharmaceuticals gets USFDA nod for hypertension drug
 ( Hot Pursuit - 29-Aug-22   11:59 )
  Alembic Pharmaceuticals consolidated net profit declines 39.70% in the December 2021 quarter
 ( Results - Announcements 10-Feb-22   15:37 )
  Alembic's Bioequivalence facility successfully concludes USFDA inspection
 ( Corporate News - 29-Aug-22   13:13 )
  Alembic Pharmaceuticals receives USFDA final approval for Arformoterol Tartrate Inhalation Solution
 ( Corporate News - 11-May-22   11:39 )
  Alembic Pharmaceuticals AGM scheduled
 ( Corporate News - 06-Jun-23   18:21 )
  Alembic Pharma gets USFDA nod for Icatibant injection
 ( Hot Pursuit - 17-Jun-24   14:03 )
  Board of Alembic Pharmaceuticals appoints director
 ( Corporate News - 10-Feb-22   16:43 )
  Alembic Pharmaceuticals to hold board meeting
 ( Corporate News - 28-Jan-22   17:38 )
  Alembic Pharmaceuticals receives USFDA tentative approval for Palbociclib Capsules
 ( Corporate News - 09-Nov-20   10:11 )
  Alembic Pharma gets US FDA nod for heart failure-treatment drug
 ( Hot Pursuit - 30-May-24   14:05 )
Other Stories
  Tridhya Tech to convene board meeting
  03-Jul-24   20:06
  Sonu Infratech schedules EGM
  03-Jul-24   19:59
  Sakuma Exports to convene AGM
  03-Jul-24   19:59
  Time Technoplast repays commercial paper
  03-Jul-24   18:31
  Board of Aditya Vision approves stock split and listing of share on NSE
  03-Jul-24   18:24
  Pricol director resigns
  03-Jul-24   18:21
  Board of VMS Industries recommends first interim dividend
  03-Jul-24   17:49
  Lakshmi Machine Works to declare Quarterly Result
  03-Jul-24   17:44
  Modison to convene AGM
  03-Jul-24   17:43
  Sybly Industries to discuss results
  03-Jul-24   17:43
Back Top